Convalescent plasma successfully treats a severe COVID-19 patient with multi-organ failure

Abstract

Due to the high mortality rate of coronavirus disease 2019 (COVID-19) and the lack of specific treatment for the disease, it is essential to find new therapies. The present case report aimed to assess the efficiency of convalescent plasma in patients with severe acute respiratory syndrome coronavirus 2. We reported a severe case of COVID-19 with multi-organ failure, who had reduced oxygen saturation after several courses of antiviral therapy. Moreover, computed tomography (CT) scan results showed patchy lesions in the base of lungs. Therapeutic measures, including endotracheal intubation and plasmapheresis with convalescent plasma, were performed for the patient; subsequently, good responses to the treatments were observed. Our findings demonstrate that convalescent plasma improves pulmonary lesions and the patient's clinical status.

Forecasting COVID-19 recovered cases with Artificial Neural Networks to enable designing an effective blood supply chain

“…This issue is addressed from many different aspects, such as the need for immediate use, supply and storage of blood and other tissues, as well as the psychological aspects of people's reluctance to donate blood, misdirection, and anxiety about getting sick. The severe progress of COVID-19 in Turkey, as in all other countries, accelerates the studies focusing on the elimination of this disease as soon as possible; and at this point, CIP therapy stands out as one of the most effective treatments to tackle the disease [ [8] , [9] , [10] , [11] ]. Recovered patients can donate plasma through the Red Crescent and pandemic hospitals in Turkey.…”